Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass

Background: Mechanisms underlying variable weight loss (WL) response after Roux-en-Y gastric bypass (RYGB) are poorly understood. The objective of this study was to compare gastrointestinal hormonal responses to meal intake, and fasting plasma concentrations of surrogate markers of enterocyte mass and bile acid effect between patients with failed (F-WL) or successful WL (S-WL) after RYGB. Methods: Cross-sectional study including 30 nondiabetic patients, evaluated at >= 24 months after RYGB. Cases (F-WL; n = 10) and controls (S-WL; n = 20) were selected based on percent of excess WL (%EWL) <50% or >= 50% from 12 months onwards after surgery. Groups were matched for gender, age, presurgical BMI, and length of follow up. Glucagon-like peptide 1 (GLP-1), peptide YY (PYY), GLP-2, and ghrelin responses to a meal challenge, and fasting plasma concentrations of citrulline and serum fibroblast growth factor 19 (FGF-19) were compared. Results: F-WL patients presented lesser suppression of ghrelin (incremental area under the curve [iAUC]: F-WL -12490 +/- 6530 versus S-WL 31196 +/- 4536 pg x mL(-1) x min; P < .01), and lesser increase in the GLP-1 (iAUC: F-WL, 3354 737 versus S-WL 5629 542 pmol x L-1 x mm; P = .02) but not in the PYY and GLP-2, response to meal intake. Citrulline concentrations were significantly correlated with time after surgery (rho = .537; P < .01). However, citrulline was higher in S-WL compared to F-WL. patients (P < .05). Serum FGF-19 concentration was similar between groups. Conclusion: Although limited by the cross-sectional design, our data suggest a role of some gastrointestinal hormones as mediators of successful weight loss but argues against larger enterocyte mass after BS as determinant of failed weight loss after RYGB. (C) 2014 American Society for Metabolic and Bariatric Surgery. All rights reserved.